The findings reported in this study show that fascin modulates the metabolites in breast cancer cells and their secretomes, extends knowledge, and contributes to the evolving understanding of fascin’s contribution to promoting breast cancer progression. This evidence concerns the gene FSCN1 and breast carcinoma.